158 related articles for article (PubMed ID: 37916954)
41. Circulating MicroRNAs for Detection of Germ Cell Tumours: A Narrative Review.
Fankhauser CD; Nuño MM; Murray MJ; Frazier L; Bagrodia A
Eur Urol Focus; 2022 May; 8(3):660-662. PubMed ID: 35537936
[TBL] [Abstract][Full Text] [Related]
42. Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle.
Gillis AJ; Rijlaarsdam MA; Eini R; Dorssers LC; Biermann K; Murray MJ; Nicholson JC; Coleman N; Dieckmann KP; Belge G; Bullerdiek J; Xu T; Bernard N; Looijenga LH
Mol Oncol; 2013 Dec; 7(6):1083-92. PubMed ID: 24012110
[TBL] [Abstract][Full Text] [Related]
43. Emerging Role of Biomarkers in Testicular Germ Cell Tumors.
Soleimani M; Kollmannsberger C; Nappi L
Curr Oncol Rep; 2022 Apr; 24(4):437-442. PubMed ID: 35142973
[TBL] [Abstract][Full Text] [Related]
44. Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience.
Saliyeva S; Boranbayeva R; Bulegenova M; Beloussov V
Pediatr Hematol Oncol; 2024; 41(2):121-134. PubMed ID: 37898912
[TBL] [Abstract][Full Text] [Related]
45. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
Murray MJ; Bell E; Raby KL; Rijlaarsdam MA; Gillis AJ; Looijenga LH; Brown H; Destenaves B; Nicholson JC; Coleman N
Br J Cancer; 2016 Jan; 114(2):151-62. PubMed ID: 26671749
[TBL] [Abstract][Full Text] [Related]
46. An Overview on Predictive Biomarkers of Testicular Germ Cell Tumors.
Chieffi P
J Cell Physiol; 2017 Feb; 232(2):276-280. PubMed ID: 27405110
[TBL] [Abstract][Full Text] [Related]
47. The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1.
Radtke A; Hennig F; Ikogho R; Hammel J; Anheuser P; Wülfing C; Belge G; Dieckmann KP
Urol Int; 2018; 100(4):470-475. PubMed ID: 29698973
[TBL] [Abstract][Full Text] [Related]
48. Recent advances in the regulation of testicular germ cell tumors by microRNAs.
Batool A; Liu XM; Zhang CL; Hao CF; Chen SR; Liu YX
Front Biosci (Landmark Ed); 2019 Mar; 24(4):765-776. PubMed ID: 30844711
[TBL] [Abstract][Full Text] [Related]
49. Application and Pitfalls of Immunohistochemistry in Diagnosis of Challenging Genitourinary Cases.
Ross J; Li G; Yang XJ
Arch Pathol Lab Med; 2020 Mar; 144(3):290-304. PubMed ID: 32101059
[TBL] [Abstract][Full Text] [Related]
50. Cost Analysis of Noninvasive Blood-Based MicroRNA Testing Versus CT Scans for Follow-up in Patients With Testicular Germ-Cell Tumors.
Charytonowicz D; Aubrey H; Bell C; Ferret M; Tsui K; Atfield R; Coleman N; Murray MJ; Wilson ECF
Clin Genitourin Cancer; 2019 Aug; 17(4):e733-e744. PubMed ID: 31155478
[TBL] [Abstract][Full Text] [Related]
51. Practical Molecular Testing in a Clinical Genitourinary Service.
Magers MJ; Cheng L
Arch Pathol Lab Med; 2020 Mar; 144(3):277-289. PubMed ID: 31373513
[TBL] [Abstract][Full Text] [Related]
52. Molecular mechanisms of regulation and action of microRNA-199a in testicular germ cell tumor and glioblastomas.
Gu S; Cheung HH; Lee TL; Lu G; Poon WS; Chan WY
PLoS One; 2013; 8(12):e83980. PubMed ID: 24391856
[TBL] [Abstract][Full Text] [Related]
53. Expression of miRNA-371a-3p in seminal plasma and ejaculate is associated with sperm concentration.
Radtke A; Dieckmann KP; Grobelny F; Salzbrunn A; Oing C; Schulze W; Belge G
Andrology; 2019 Jul; 7(4):469-474. PubMed ID: 31310058
[TBL] [Abstract][Full Text] [Related]
54. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.
Anheuser P; Radtke A; Wülfing C; Kranz J; Belge G; Dieckmann KP
Urol Int; 2017; 99(1):98-103. PubMed ID: 28586780
[TBL] [Abstract][Full Text] [Related]
55. The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - A Focus on signaling pathways interplay.
Doghish AS; Moustafa HAM; Elballal MS; Sallam AM; El-Dakroury WA; Abdel Mageed SS; Elesawy AE; Abdelmaksoud NM; Shahin RK; Midan HM; Elrebehy MA; Elazazy O; Nassar YA; Elazab IM; Elballal AS; Elballal MS; Abulsoud AI
Pathol Res Pract; 2023 Aug; 248():154611. PubMed ID: 37315401
[TBL] [Abstract][Full Text] [Related]
56. MicroRNAs: Turning the Tide in Testicular Cancer.
Singla N; Lafin JT; Bagrodia A
Eur Urol; 2019 Nov; 76(5):541-542. PubMed ID: 31230742
[TBL] [Abstract][Full Text] [Related]
57. Serum Level of microRNA-375-3p Is Not a Reliable Biomarker of Teratoma.
Belge G; Grobelny F; Matthies C; Radtke A; Dieckmann KP
In Vivo; 2020; 34(1):163-168. PubMed ID: 31882475
[TBL] [Abstract][Full Text] [Related]
58. Tumor-suppressive function of protein-tyrosine phosphatase non-receptor type 23 in testicular germ cell tumors is lost upon overexpression of miR142-3p microRNA.
Tanaka K; Kondo K; Kitajima K; Muraoka M; Nozawa A; Hara T
J Biol Chem; 2013 Aug; 288(33):23990-9. PubMed ID: 23843459
[TBL] [Abstract][Full Text] [Related]
59. Pediatric genitourinary tumors.
McLean TW; Castellino SM
Curr Opin Oncol; 2008 May; 20(3):315-20. PubMed ID: 18391632
[TBL] [Abstract][Full Text] [Related]
60. MicroRNAs in Testicular Cancer Diagnosis and Prognosis.
Ling H; Krassnig L; Bullock MD; Pichler M
Urol Clin North Am; 2016 Feb; 43(1):127-34. PubMed ID: 26614035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
